Access count of this item: 152

Files in This Item:
File Description SizeFormat 
26_0603.pdf853.97 kBAdobe PDFView/Open
Title: 慢性複雑性尿路感染症に対するKW-1062とGentamicinの二重盲検法による有効性および安全性の検討
Other Titles: DOUBLE-BLIND TRIAL OF KW-1062 AND GENTAMICIN IN CHRONIC COMPLICATED URINARY TRACT INFECTION
Authors: 石神, 襄次  KAKEN_name
藤井, 昭男  KAKEN_name
熊本, 悦明  KAKEN_name
宮本, 慎一  KAKEN_name
大越, 正秋  KAKEN_name
河村, 信夫  KAKEN_name
西浦, 常雄  KAKEN_name
坂, 義人  KAKEN_name
前田, 真一  KAKEN_name
名出, 頼男  KAKEN_name
鈴木, 恵三  KAKEN_name
長久保, 一朗  KAKEN_name
古沢, 太郎  KAKEN_name
大森, 弘之  KAKEN_name
松村, 陽右  KAKEN_name
石戸, 則孝  KAKEN_name
黒川, 一男  KAKEN_name
藤村, 宣夫  KAKEN_name
百瀬, 俊郎  KAKEN_name
熊沢, 浄一  KAKEN_name
中牟田, 誠一  KAKEN_name
河野, 博巳  KAKEN_name
江藤, 耕作  KAKEN_name
宮原, 茂  KAKEN_name
岡元, 健一郎  KAKEN_name
大井, 好忠  KAKEN_name
川畠, 尚志  KAKEN_name
上野, 一恵  KAKEN_name
渡辺, 邦友  KAKEN_name
池田, 潤平  KAKEN_name
坂元, 保秀  KAKEN_name
三木, 文雄  KAKEN_name
Author's alias: Ishigami, Joji
Fujii, Akio
Kumamoto, Yoshiaki
Miyamoto, Shinichi
Ohkoshi, Masaaki
Kawamura, Nobuo
Nishiura, Tsuneo
Ban, Yoshito
Maeda, Shinichi
Naide, Yorio
Suzuki, Keizo
Nagakubo, Ichiro
Furusawa, Taro
Omori, Hiroyuki
Matsumura, Yosuke
Ishido, Noritaka
Kurokawa, Kazuo
Fujimura, Nobuo
Momose, Shunro
Kumazawa, Seiichi
Nakamuta, Seiichi
Kawano, Hiromi
Eto, Kosaku
Miyahara, Shigeru
Okamoto, Kenichiro
Ohi, Yoshitada
Kawabata, Takashi
Ueno, Kazue
Watanabe, Kunitomo
Ikeda, Junpei
Sakamoto, Yasuhide
Miki, Fumio
Issue Date: May-1980
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 26
Issue: 5
Start page: 603
End page: 617
Abstract: In order to examine effectiveness, safety and usefulness of, KW-l062, a new aminoglycoside antibiotic, it was compared with gentamicin (GM) for treatment of chronic complicated urinary tract infection in a double-blind trial. KW-I062 was administered to hospitalized adult patients at the dosage of 120 mg b.i.d. for five days. GM was administered to hospitalized adult patients at the dosage of 60 mg b.i.d. for five days. The number of evaluable cases was 105 for KW-1062 and 95 for GM, and the results obtained were as follows. 1) No significant difference was observed between the KW-1062 group and GM group in various background factors related to the characteristic of patients. 2) KW-l062 showed a significantly higher rate of efficacy on bacteriuria and overall clinical efficacy (p<0.05). 3) Side effects and abnormal laboratory findings occurred at a low frequency in both treatment groups, and there were no significant differences between both groups.
URI: http://hdl.handle.net/2433/122638
Appears in Collections:Vol.26 No.5

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.